US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about Bruce Cozadd

Recent news which mentions Bruce Cozadd

Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth?
Tickers JAZZ NEWS
Tags Markets Trading Ideas Earnings
From Benzinga
Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues?
Tickers JAZZ
Tags Jazz Pharmaceuticals Benzinga Cannabis Capital Conference Earnings
From Benzinga
Jazz Pharma Q1 FY23 Revenue Grows 10% YoY, What About Net Income?
Tickers JAZZ
Tags Markets premium Earnings
From Benzinga
Jazz Q4 2022 Revenue Grows 8% To $972M, Provides Outlook
Tickers JAZZ
Tags Cannabis Bruce Cozadd News
From Benzinga
Jazz Pharmaceuticals Completes U.S. Divestiture Of Sunosi To Axsome Therapeutics, What's Next?
Tickers AXSM JAZZ
Tags Cannabis Bruce Cozadd M&A
From Benzinga
Jazz Pharma Reports Q1 Epidiolex Sales Increased 6% To $157.9M YoY
Tickers JAZZ
Tags Market News Earnings Markets
From Benzinga
Lab Notes: Jazz agrees to multimillion-dollar drug sale; Lannett takes 'major step' with biosimilar
Tickers INNO
Tags Tim Crew Madeline Bell Lannett Co Inc
From Business Journals
Court Dismisses Canopy's Cannabis Patent Infringement Lawsuit Against Jazz's GW Pharma
Tickers CGC JAZZ
Tags Epidiolex Market News Marijuana Business Daily
From Benzinga
Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results
Tickers JAZZ
Tags Cannabis After/Hours Center Jazz Pharmaceuticals earnings
From Benzinga